UroToday
UroToday features reliable clinical information that is systematically categorized by diseases, treatments, and guidelines. This educational platform provides a variety of resources, including written articles, video lectures, discussions, and new research findings shared at conferences. The content is carefully curated and presented by esteemed experts in the field of urology. Additionally, UroToday has a dedicated portal where users can find information about ongoing clinical trials. The Centers of Excellence (CoE) offer advanced lectures, original research, and articles organized by specific diseases and conditions, focusing on established and emerging treatment options in clinical practice. Each CoE is managed by a clinician-editor along with selected faculty members.
Outlet metrics
Global
#300265
United States
#152792
Health/Health Conditions and Concerns
#363
Articles
-
1 month ago |
urotoday.com | Adam P. Dicker
Read the Full Video TranscriptAlicia Morgans: Hi. I'm so excited to be here today, talking with Dr. Adam Dicker at GU ASCO 2025. He's joining me from Thomas Jefferson University. Thank you so much for being here. Adam P. Dicker: My pleasure. Alicia Morgans: Wonderful. So there's been a lot of excitement about MMAI, this artificial intelligence that helps us really understand pathology specimens on a deeper level, maybe being prognostic or predictive of certain outcomes for patients.
-
2 months ago |
urotoday.com | Mark Tyson
Read the Full Video TranscriptAshish Kamat: Hello everyone, and welcome to UroToday. I'm Ashish Kamat, Professor of Urologic Oncology at M.D. Anderson Cancer Center, and it's a pleasure to welcome to the forum once again someone who's been with us many times, Professor Mark Tyson from Phoenix, Arizona, and also his mentee, a pre-med student, Jacob Moyer. So welcome to the forum, guys. Mark Tyson: Thank you, Dr. Kamat. Pleasure to be here. Jacob Moyer: Great to be here. Thanks for having us.
-
2 months ago |
urotoday.com | Laura Sena
Read the Full Video TranscriptAndrea Miyahira: Hi, everyone. I'm Andrea Miyahira at the Prostate Cancer Foundation. I'm pleased to welcome Dr. Laura Sena from Johns Hopkins University, who will discuss her recent paper, "Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancer," published in NPJ Precision Oncology. Dr. Sena, thank you for coming on today. Laura Sena: Thanks so much for having me, Andrea.
-
2 months ago |
urotoday.com | Yair Lotan
Read the Full Video TranscriptAshish Kamat: Hello, everyone, and welcome to UroToday's Bladder Cancer Center of Excellence. I'm Ashish Kamat, a urologic oncologist at MD Anderson Cancer Center.
-
2 months ago |
urotoday.com | Yair Lotan
Read the Full Video TranscriptAshish Kamat: Hello, everybody, and welcome to UroToday's bladder Cancer Center of Excellence. I'm Ashish Kamat, urologic oncologist at M.D. Anderson Cancer Center. And it's a distinct pleasure to welcome once again, Professor Yair Lotan. He's a urologic oncologist at UT Southwestern in Dallas. Yair, thank you so much for taking the time today.
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://urotoday.comTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →